1 / 13

百特与您携手， 促进合理用药，共筑患者安全 百特（中国）投资有限公司

百特与您携手， 促进合理用药，共筑患者安全 百特（中国）投资有限公司. 在汶川、在王家岭， 百特输液带来生的希望！. HAIs affect millions of patients worldwide each year and take thousands of lives 每年全世界数以百万计的病人受院内感染影响，并有数万人因此丧命. At any time, over 1.4 million people across the globe are suffering from an HAI 1 每时每刻，全世界超过 140 万人正遭受院内感染的危害

murphy-waters
Download Presentation

百特与您携手， 促进合理用药，共筑患者安全 百特（中国）投资有限公司

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 百特与您携手， 促进合理用药，共筑患者安全 百特（中国）投资有限公司

  2. 在汶川、在王家岭， 百特输液带来生的希望！

  3. HAIs affect millions of patients worldwide each year and take thousands of lives每年全世界数以百万计的病人受院内感染影响，并有数万人因此丧命 • At any time, over 1.4 million people across the globe are suffering from an HAI1每时每刻，全世界超过140万人正遭受院内感染的危害 • HAIs are associated with significant mortality院内感染致死率相当高 • Over 5000 deaths occur each year in England1英国每年超过5,000名病人死于院内感染 • 32 deaths occur per 100,000 inhabitants each year in Mexico1 墨西哥的院内感染致死率为0.32 ‰ • Over 50,000 deaths occur each year in the European Union2 在欧盟，每年超过50,000人因院内感染死亡 • Approx 1.7 million HAIs occur each year in the US, responsible for 100,000 deaths and $30.5 billion in excess costs • The risk that a patient will develop an HAI is high: 病人获得院内感染的风险很高 • 1 in 20 in the US3 and as high as 1 in 4 in developing countries1 在美国，每20个病人就有1人有此风险，而在发展中国家，每4个病人中，就有1人可能遭受院内感染 • WHO. World Alliance for Patient Safety. Global Patient Safety Challenge Program 2005-2006. Geneva Switzerland. • European Center for Disease Prevention and Control. Annual Epidemiological Report on Communicable Diseases in Europe. Available at: http://ecdc.europa.eu/pdf/ECDC_epi_report_2007.pdf. Accessed August 2008. • Wenzel RP, Edmond MB. Emerg Infect DIs. 2001;7:174-177.

  4. International annual estimates offatalities resulting from ME 预计每年全球因用药错误导致的死亡人数 • How much can we rely on this estimate? • 因用药错误死亡的人数仅有这些吗？

  5. Switching from an open to a closed system significantly reduced the rate of CLABSI从开放式系统向密闭式系统转换显著减少BSI发生率 Open system phase开放式输液 Closed system phase密闭式输液系统 8.2 P=0.01 P=0.02 6.5 BSI Rate per 1000 CVC days 3.5 2.4 Italy2意大利 (N=1173) Argentina1阿根廷 (N=992) • Rosenthal VD, Maki DG. Am J Infect Control. 2004;32:135-141. • Tarricone R et al. Presented at the 8th Annual Meeting of the International Federation of Infection Control; October 18-21, 2007; Budapest, Hungary.

  6. Various delivery systems exist 现存的多样的输注系统 Reconstitution Systems 复配系统 2 Components 2个组件 Ready To Mix: Vial + IV Bag 预混液：针剂+输液 3 Components3个组件 Manual Admixing: Syringe + Vial + IV Bag人工配置：针筒+针剂+输液 1 Component 1个组件 Ready To Use: IV bag with drug 即用型（Ready-to-use）: 含药输液 Path to lower BSI and Med Error降低BSI和输注错误 Glass玻瓶 Containers包装 Semi-Rigid塑瓶 Flexible软袋

  7. Update on 2nd Consensus Second Consensus Development Conference on the Safety of Intravenous Drug Delivery Systems——2008 2008年第二届“静脉药物输注系统”发展共识会议 适用性 易用性 合规性 成本 安全性 可执行性 Nonpharmacy Compounded at Point of Care 非药房/即时配置 Manufacturer Ready-to-Use 预配液，即用型 Outsource Ready-to-Use 外包，预混液 Point-of-Care Activated 床旁激活 Pharmacy Compounded 药房配置 Highest Score 最高分 Michael D. Sanborn, Mary L. Moody et al. Am J Health-Syst Pharm. 2009; 66:185-92

  8. 百特药物输注部——我们的产品和服务 • Premix即用型全密闭软袋输液产品（治疗性输液） • 原料准备、生产工艺、产品包材、药物储藏、药物输注 • 执行严格的生产工艺流程 • 双阀双层灭菌包装全密闭软袋输液 • 即用型，输液前无需人工配置，减少给药差错和配置差错，使用更方便 • 百特从1998年进入中国，一直采用“双层灭菌包装工艺”： 全程品质保障，让经典更可靠、更方便！

  9. 百特药物输注部——我们的产品和服务 • Premix即用型全密闭软袋输液产品（治疗性输液） • 氟康唑氯化钠注射液——预防和治疗念珠菌感染的指南推荐用药 • 盐酸左氧氟沙星氯化钠注射液——治疗各种感染的经验之选 • 国家基本药物 • 甲硝唑注射液——治疗厌氧菌感染的重要选用药物 • 国家基本药物 • 20％甘露醇注射液——最广泛应用的渗透性脱水剂 • 国家基本药物 全程品质保障，让经典更可靠、更方便！

  10. 百特药物输注部——我们的产品和服务 • 静脉药物配置中心 • 门急诊输液中心 • 病区/PIVAS双向可视管理平台 • 目视管理 VM • 条形码管理 Gateway • 药学培训项目 Pharmacy Training Program • 用药安全时讯 <Medication Safety Newsletter> • 。。。 促进合理用药，提高患者安全

  11. 百特药物输注部——我们的使命 “百特愿通过领先的输液产品和技术，通过持续升级的增值服务，从细节入手，从点滴做起，与您携手为不断提升医疗质量、提高患者安全做出努力！” 百特药物输注部高级业务总监 王高芳

  12. 百特与您携手， 促进合理用药，共筑患者安全 百特（中国）投资有限公司

More Related